Continuing surgical education

Kirstie Kirkley, Georgia R. Layton, Javeria Tariq, Heen Shamaz, Mostin Hu, Alana Atkinson, Deborah Harrington, Elizabeth Belcher, Jason Ali, Narain Moorjani, Farah Bhatti, Karen Booth

Jonothan J Earnshaw DM FRCS

Michele Cricrì, Antonio Miele, Francesca Paola Tropeano, Giovanni De Palma, Gaetano Luglio

Theophilus TK Anyomih, Antonio Ramos De La Medina, Laura Martinez

Jonothan Earnshaw, Directory of BJS Academy, delivers his talk ‘Future of scientific surgical publication’. A reprise of his presentation at the Association of Surgeons of Great Britain and Ireland (ASGBI)’s 2024 Annual Meeting.

Ville Sallinen

Ville Sallinen, Editor-in-chief of BJS Open, gives an ACTA lecture on How to write a scientific surgical manuscript and be published' at the Swedish Surgical Society's 2024 Kirurgveckan.

Roberto Iezzi, MD, fCIRSE, Anna Rita Scrofani, MD, Alessandro Posa, MD

Introduction Haemorrhoids are one of the most common benign pathologies of the anorectal area, with a prevalence of 4.4-39% 1. Haemorrhoids are equally distributed among women and men, being most common between 45 and 65 years 2. Risk factors for haemorrhoids include chronic constipation, obesity, pregnancy, and old age 1. Recurrent rectal bleeding is the most common presentation. Other clinical presentations are prolapse and anal pruritus due to tissue exudation. In the advanced phases of disease, pain is frequently reported related to thrombosis, fissure formation or anal gland infection 3. The aforementioned symptoms lead to a reduction in quality of life. Haemorrhoids are classified in 4 grades, based on the degree of prolapse using the Goligher classification (Table 1) 4.

Matti Tolonen, MD, PhD, presents his BJS Lecture “Emergency general surgery model and acute mesenteric ischaemia – pathway” from the 2024 Association of Surgeons of Great Britain and Ireland (ASGBI) International Surgical Congress.

Sian Farrell presents her BJS Prize winning lecture “Tumour targeted oxygen-generating nanoparticles for enhanced radiotherapy in the treatment of pancreatic cancer” from the 2024 Association of Surgeons of Great Britain and Ireland (ASGBI) International Surgical Congress.